Podcast Episodes
Back to Search
Congress to Clinic: Expert Takeaways on Emerging Data for AML
Episode 174
In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) prese…
1 year, 11 months ago
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
Episode 173
In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic…
1 year, 11 months ago
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
Episode 172
In this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the l…
2 years, 1 month ago
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Episode 169
In this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share str…
2 years, 1 month ago
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
Episode 168
In this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing t…
2 years, 3 months ago
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
Episode 167
In this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for pa…
2 years, 3 months ago
Current Considerations for Adverse Event Management With HER3-Directed Agents
Episode 165
The third and final episode in a 3-part series covers the safety profile of and considerations for managing adverse events associated with HER3-targe…
2 years, 6 months ago
Unpacking the Potential of HER3-Targeted Therapy in NSCLC
Episode 164
This second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including:
Recent d…2 years, 6 months ago
Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer
Episode 166
This first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs.
P…
2 years, 6 months ago
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
Episode 163
In this episode, Brian Slomovitz, MD, MS, FACOG, and Keiichi Fujiwara, MD, PhD, share their thoughts and opinions on seminal data presented at the 20…
2 years, 6 months ago